#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#
CS
proLékaře.cz / Journals / Internal Medicine / 2019 - 1

Diagnostic pitfalls of celiac disease

Czech version

Authors: Iva Hoffmanová 1;  Daniel Sánchez 2;  Helena Tlaskalová Hogenová 2
Authors‘ workplace: II. interní klinika 3. LF UK a FN Královské Vinohrady, Praha 1;  Laboratoř buněčné a molekulární imunologie Mikrobiologického ústavu AV ČR, v. v. i., Praha 2
Published in: Vnitř Lék 2019; 65(1): 24-29
Category:

Overview

Celiac disease is a very common autoimmune disorder caused by the ingestion of dietary gluten products in genetically susceptible persons. Its global prevalence is estimated around 1 %. However, the most cases are not diagnosed. Clinical presentation is widely variable with the involvement of various human systems. Besides a clinical picture (that is often non characteristic), the diagnosis is based on positivity of serological testing (tissue transglutaminase autoantibodies) and histological evaluation of small intestinal mucosa. The article presents a rational diagnostic approach to celiac disease.

Key words:

celiac disease – Marsh classification – tissue transglutaminase autoantibodies – villous atrophy

Sources
  1. Frič P, Zavoral M, Dvořáková T. Gluten induced diseases. Vnitř Lék 2013; 59(5): 376–382.
  2. Věstník Ministerstva zdravotnictví České republiky. Ročník 2011, částka 3. Strana 51–54. Vydáno 28. února 2011. Dostupné z WWW: <https://www.mzcr.cz/Legislativa/dokumenty/vestnik-c_4741_2162_11.html>.
  3. Chou R, Bougatsos C, Blazina I et al. Screening for Celiac Disease: Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA 2017; 317(12): 1258–1268. Dostupné z DOI: <http://dx.doi.org/10.1001/jama.2016.10395>.
  4. Parzanese I, Qehajaj D, Patrinicola F et al. Celiac disease: From pathophysiology to treatment. World J Gastrointest Pathophysiol 2017; 8(2): 27–38. Dostupné z DOI: <http://dx.doi.org/10.4291/wjgp.v8.i2.2>.
  5. Frič P, Keil R. Celiakie pro praxi. Med Praxi 2011; 8(9): 354–359.
  6. Downey L, Houten R, Murch S et al. Recognition, assessment, and management of coeliac disease: summary of updated NICE guidance. BMJ 2015; 351: h4513. Dostupné z DOI: <http://dx.doi.org/10.1136/bmj.h4513>.
  7. Husby S, Koletzko S, Korponay-Szabo IR et al. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr 2012; 54(1): 136–160. Dostupné z DOI: <http://dx.doi.org/10.1097/MPG.0b013e31821a23d0>. Erratum in J Pediatr Gastroenterol Nutr 2012; 54(4): 572.
  8. Leffler D, Schuppan D, Pallav K et al. Kinetics of the histological, serological and symptomatic responses to gluten challenge in adults with coeliac disease. Gut 2013; 62(7): 996–1004. Dostupné z DOI: <http://dx.doi.org/10.1136/gutjnl-2012–302196>.
  9. Rubio-Tapia A, Hill ID, Kelly CP et al. ACG clinical guidelines: diagnosis and management of celiac disease. Am J Gastroenterol 2013; 108: 656–676; quiz 677. Dostupné z DOI: <http://dx.doi.org/10.1038/ajg.2013.79>.
  10. Sarna VK, Lundin, Knut E A et al. HLA-DQ-Gluten Tetramer Blood Test Accurately Identifies Patients With and Without Celiac Disease in Absence of Gluten Consumption. Gastroenterology 2018; 154(4): 886–896.e6. Dostupné z DOI: <http://dx.doi.org/10.1053/j.gastro.2017.11.006>.
  11. Sarna VK, Skodje GI, Reims HM et al. HLA-DQ: gluten tetramer test in blood gives better detection of coeliac patients than biopsy after 14-day gluten challenge. Gut 2018; 67(9): 1606–1613. Dostupné z DOI: <http:///dx.doi.org/10.1136/gutjnl-2017–314461>.
  12. Kocna P, Vaníčková Z, Perušičová J et al. Tissue transglutaminase-serology markers for coeliac disease. Clin Chem Lab Med 2002; 40(5): 485–492. Dostupné z DOI: <http://dx.doi.org/10.1515/CCLM.2002.084>.
  13. Nevoral J, Kotalová R, Hradský O et al. Symptom positivity is essential for omitting biopsy in children with suspected celiac disease according to the new ESPGHAN guidelines. Eur J Pediatr 2014; 173(4): 497–502. Dostupné z DOI: <http://dx.doi.org/10.1007/s00431–013–2215–0>.
  14. Wolf J, Petroff D, Richter T et al. Validation of Antibody-Based Strategies for Diagnosis of Pediatric Celiac Disease Without Biopsy. Gastroenterology 2017; 153(2): 410–419. Dostupné z DOI: <http://dx.doi.org/10.1053/j.gastro.2017.04.023>.
  15. Tortora R, Imperatore N, Capone P et al. The presence of anti-endomysial antibodies and the level of anti-tissue transglutaminases can be used to diagnose adult coeliac disease without duodenal biopsy. Aliment Pharmacol Ther 2014; 40(10): 1223–1229. Dostupné z DOI: <http://dx.doi.org/10.1111/apt.12970>.
  16. Holmes GKT, Forsyth JM, Knowles S et al. Coeliac disease: further evidence that biopsy is not always necessary for diagnosis. Eur J Gastroenterol Hepatol 2017; 29(6): 640–645. Dostupné z DOI: <http://dx.doi.org/10.1097/MEG.0000000000000841>.
  17. Zanini B, Magni A, Caselani F et al. High tissue-transglutaminase antibody level predicts small intestinal villous atrophy in adult patients at high risk of celiac disease. Dig Liver Dis 2012; 44(4): 280–285. Dostupné z DOI: <http://dx.doi.org/10.1016/j.dld.2011.10.013>.
  18. Wakim-Fleming J, Pagadala MR, Lemyre MS et al. Diagnosis of celiac disease in adults based on serology test results, without small-bowel biopsy. Clin Gastroenterol Hepatol 2013; 11(5): 511–516. Dostupné z DOI: <http://dx.doi.org/10.1016/j.cgh.2012.12.015>.
  19. Leffler DA, Schuppan D. Update on serologic testing in celiac disease. Am J Gastroenterol 2010; 105(12): 2520–2524. Dostupné z DOI: <http://dx.doi.org/10.1038/ajg.2010.276>.
  20. Kurien M, Mooney PD, Sanders DS. Editorial: is a histological diagnosis mandatory for adult patients with suspected coeliac disease? Aliment Pharmacol Ther 2015; 41(1): 146–147. Dostupné z DOI: <http://dx.doi.org/10.1111/apt.13002>.
  21. Mills JR, Murray JA. Contemporary celiac disease diagnosis: is a biopsy avoidable? Curr Opin Gastroenterol 2016; 32(2): 80–85. Dostupné z DOI: <http://dx.doi.org/10.1097/MOG.0000000000000245>.
  22. Taavela J, Popp A, Korponay-Szabo IR et al. A Prospective Study on the Usefulness of Duodenal Bulb Biopsies in Celiac Disease Diagnosis in Children: Urging Caution. Am J Gastroenterol 2016; 111(1): 124–133. Dostupné z DOI: <http://dx.doi.org/10.1038/ajg.2015.387>.
  23. Lau MS, Sanders DS. Optimizing the diagnosis of celiac disease. Curr Opin Gastroenterol 2017; 33(3): 173–180. Dostupné z DOI: <http://dx.doi.org/10.1097/MOG.0000000000000343>.
  24. Iovino P, Pascariello A, Russo I et al. Difficult diagnosis of celiac disease: diagnostic accuracy and utility of chromo-zoom endoscopy. Gastrointest Endosc 2013; 77(2): 233–240. Dostupné z DOI: <http://dx.doi.org/10.1016/j.gie.2012.09.036>.
  25. Ianiro G, Gasbarrini A, Cammarota G. Endoscopic tools for the diagnosis and evaluation of celiac disease. World J Gastroenterol. 2013; 19(46): 8562–8570. Dostupné z DOI: <http://dx.doi.org/10.3748/wjg.v19.i46.8562>.
  26. Ianiro G, Bibbo S, Pecere S et al. Current technologies for the endoscopic assessment of duodenal villous pattern in celiac disease. Comput Biol Med 2015; 65: 308–314. Dostupné z DOI: <http://dx.doi.org/10.1016/j.compbiomed.2015.04.033>.
  27. Marsh MN. Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity (“celiac sprue”). Gastroenterology 1992; 102(1): 330–354.
  28. Oberhuber G, Granditsch G, Vogelsang H. The histopathology of coeliac disease: time for a standardized report scheme for pathologists. Eur J Gastroenterol Hepatol 1999; 11(10): 1185–1194.
  29. Dickson BC, Streutker CJ, Chetty R. Coeliac disease: an update for pathologists. J Clin Pathol 2006; 59(10): 1008–1016. Dostupné z DOI: <http://dx.doi.org/10.1136/jcp.2005.035345>.
  30. Hayat M, Cairns A, Dixon MF et al. Quantitation of intraepithelial lymphocytes in human duodenum: what is normal? J Clin Pathol 2002; 55(5): 393–394.
  31. Jarvinen TT, Collin P, Rasmussen M et al. Villous tip intraepithelial lymphocytes as markers of early-stage coeliac disease. Scand J Gastroenterol 2004; 39(5): 428–433.
  32. Korponay-Szabo IR, Troncone R, Discepolo V. Adaptive diagnosis of coeliac disease. Best Pract Res Clin Gastroenterol 2015; 29(3): 381–398. Dostupné z DOI: <http://dx.doi.org/10.1016/j.bpg.2015.05.003>.
  33. Martins C, Teixeira C, Ribeiro S et al. Seronegative Intestinal Villous Atrophy: A Diagnostic Challenge. Case Rep Gastrointest Med 2016; 2016: 6392028. Dostupné z DOI: <http://dx.doi.org/10.1155/2016/6392028>.
  34. Kamboj AK, Oxentenko AS. Clinical and Histologic Mimickers of Celiac Disease. Clin Transl Gastroenterol 2017; 8(8): e114. Dostupné z DOI: <http://dx.doi.org/10.1038/ctg.2017.41>.
  35. Mubarak A, Wolters VM, Houwen RH et al. Immunohistochemical CD3 staining detects additional patients with celiac disease. World J Gastroenterol 2015; 21(24): 7553–7557. Dostupné z DOI: <http://dx.doi.org/10.3748/wjg.v21.i24.7553>.
  36. Hudacko R, Kathy ZX, Yantiss RK. Immunohistochemical stains for CD3 and CD8 do not improve detection of gluten-sensitive enteropathy in duodenal biopsies. Mod Pathol 2013; 26(9): 1241–1215. Dostupné z DOI: <http://dx.doi.org/10.1038/modpathol.2013.57>.
  37. Elli L, Zini E, Tomba C et al. Histological evaluation of duodenal biopsies from coeliac patients: the need for different grading criteria during follow-up. BMC Gastroenterol 2015; 15: 133. Dostupné z DOI: <http://dx.doi.org/10.1186/s12876–015–0361–8>.
  38. Corazza GR, Villanacci V, Zambelli C et al. Comparison of the interobserver reproducibility with different histologic criteria used in celiac disease. Clin Gastroenterol Hepatol 2007; 5(7): 838–843. Dostupné z DOI: <http://dx.doi.org/10.1016/j.cgh.2007.03.019>.
  39. Wolters VM, Wijmenga C. Genetic background of celiac disease and its clinical implications. Am J Gastroenterol 2008; 103(1): 190–195. Dostupné z DOI: <http://dx.doi.org/10.1111/j.1572–0241.2007.01471.x>.
  40. Dieli-Crimi R, Cenit MC, Nunez C. The genetics of celiac disease: A comprehensive review of clinical implications. J Autoimmun 2015; 64: 26–41. Dostupné z DOI: <http://dx.doi.org/10.1016/j.jaut.2015.07.003>.
  41. Catassi C, Fasano A. Celiac disease diagnosis: simple rules are better than complicated algorithms. Am J Med 2010; 123(8): 691–693. Dostupné z DOI: <http://dx.doi.org/10.1016/j.amjmed.2010.02.019>.
  42. Bodd M, Tollefsen S, Bergseng E et al. Evidence that HLA-DQ9 confers risk to celiac disease by presence of DQ9-restricted gluten-specific T cells. Hum Immunol 2012; 73(4): 376–381. Dostupné z DOI: <http://dx.doi.org/10.1016/j.humimm.2012.01.016>.
  43. Ricano-Ponce I, Wijmenga C, Gutierrez-Achury J. Genetics of celiac disease. Best Pract Res Clin Gastroenterol 2015; 29(3): 399–412. Dostupné z DOI: <http://dx.doi.org/10.1016/j.bpg.2015.04.004>.
  44. Villanacci V, Ceppa P, Tavani E et al. Coeliac disease: the histology report. Dig Liver Dis 2011; 43(Suppl 4): S385-S395. Dostupné z DOI: <http://dx.doi.org/10.1016/S1590–8658(11)60594-X>.
  45. Ierardi E, Losurdo G, Piscitelli D et al. Seronegative celiac disease: where is the specific setting? Gastroenterol Hepatol Bed Bench 2015; 8(2): 110–116.
  46. Volta U, Caio G, Boschetti E et al. Seronegative celiac disease: Shedding light on an obscure clinical entity. Dig Liver Dis 2016; 48(9): 1018–1022. Dostupné z DOI: <http://dx.doi.org/10.1016/j.dld.2016.05.024>.
  47. Aziz I, Peerally MF, Barnes J et al. The clinical and phenotypical assessment of seronegative villous atrophy; a prospective UK centre experience evaluating 200 adult cases over a 15-year period (2000–2015). Gut 2017; 66(9): 1563–1572. Dostupné z DOI: <http://dx.doi.org/10.1136/gutjnl-2016–312271>.
  48. Volta U, Caio G, Giancola F et al. Features and Progression of Potential Celiac Disease in Adults. Clin Gastroenterol Hepatol 2016; 14(5): 686–693. Dostupné z DOI: <http://dx.doi.org/10.1016/j.cgh.2015.10.024>.
  49. Ho-Yen C, Chang F, van der Walt J et al. Recent advances in refractory coeliac disease: a review. Histopathology 2009; 54(7): 783–795. Dostupné z DOI: <http://dx.doi.org/10.1111/j.1365–2559.2008.03112.x>.
  50. Smedby KE, Akerman M, Hildebrand H et al. Malignant lymphomas in coeliac disease: evidence of increased risks for lymphoma types other than enteropathy-type T cell lymphoma. Gut 2005; 54(1): 54–59. Dostupné z DOI: <http://dx.doi.org/10.1136/gut.2003.032094>.
  51. Richir M, Songun I, Wientjes C et al. Small Bowel Adenocarcinoma in a Patient with Coeliac Disease: Case Report and Review of the Literature. Case Reports Gastroenterol 2010; 4(3): 416–420. Dostupné z DOI: <http://dx.doi.org/10.1159/000313547>.
  52. Ozgor B, Selimoglu MA. Coeliac disease and reproductive disorders. Scand J Gastroenterol 2010; 45(4): 395–402. Dostupné z DOI: <http://dx.doi.org/10.3109/00365520903508902>.
  53. Sapone A, Bai JC, Ciacci C et al. Spectrum of gluten-related disorders: consensus on new nomenclature and classification. BMC Med 2012; 10: 13. Dostupné z DOI: <http://dx.doi.org/10.1186/1741–7015–10–13>.
Labels
Diabetology Endocrinology Internal medicine
Prescription and dosage of RAAS inhibitors in patients with chronic heart failure in the FAR NHL registry
Non-celiac gluten/wheat sensitivity: still more questions than answers
Potential possibility of phosphocreatine usage in internal medicine
Systemic inflammatory response with high CRP values as the dominant symptom of multiple myeloma
Direct oral anticoagulants in oncology in clinical praxis
The combination of acromegaly and Klinefelter syndrome in one patient
Article was published in

Internal Medicine

Issue 1
2019 Issue 1
Most read in this issue
Journals
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#